Rare antibodies with potential to combat alpha-gal syndrome identified

National Institutes of Health (NIH) researchers have discovered rare antibodies that could inform the development of an intervention for alpha-gal syndrome (AGS), an emerging tick bite-associated condition that can lead to allergic reactions to a molecule in red meat and other animal products. In laboratory tests, these antibodies acted as a biological shield, blocking human allergic antibodies from binding to red meat allergens. The findings were published in the Journal of Clinical Investigation.

≈